MONDAY, Nov. 9, 2020 — Low-dose computed tomography (LDCT) chest scans obtained for other reasons…
View More Low-Dose CT Offers Opportunity to Screen for Osteoporosis
Antibody Treatment Approved for Emergency Use Against Early COVID-19
TUESDAY, Nov. 10, 2020 — Eli Lilly’s experimental antibody treatment for COVID-19 was given emergency…
View More Antibody Treatment Approved for Emergency Use Against Early COVID-19
Testing timeline: What’s ahead for COVID-19 vaccines
Pfizer’s surprising news that its COVID-19 vaccine might offer more protection than anticipated—an announcement right…
View More Testing timeline: What’s ahead for COVID-19 vaccines
Case study details leukemia patient who shed infectious SARS-CoV-2 for at least 70 days
The majority of people infected with SARS-CoV-2 appear to actively shed infectious virus for about…
View More Case study details leukemia patient who shed infectious SARS-CoV-2 for at least 70 days
Coronavirus vaccine results fuel hopes for return to normal
Hugely promising results from a coronavirus vaccine trial fuelled optimism around the world Tuesday that…
View More Coronavirus vaccine results fuel hopes for return to normal
New prognostic markers for colon cancer identified
Gut-associated lymphoid tissue represents an integral part of the immune system. Among the powerful players…
View More New prognostic markers for colon cancer identified
Higher COVID-19 Rates Seen for First Responders
MONDAY, Nov. 2, 2020 — The COVID-19 infection rate among first responders in New York…
View More Higher COVID-19 Rates Seen for First Responders
Putin says no plans for new lockdown despite record virus surge
President Vladimir Putin said on Thursday there were no plans for a new lockdown in…
View More Putin says no plans for new lockdown despite record virus surge
How allergens trigger itching: Finding points to new targets for allergy drug development
A key step in the immune system’s response to allergens has been uncovered by researchers…
View More How allergens trigger itching: Finding points to new targets for allergy drug development
NHGRI publishes new vision for human genomics
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH),…
View More NHGRI publishes new vision for human genomics